Cell Source, Inc. (CLCS)

Cell Source Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.07	0.02	0.22	0.09	0.24
Cash & Short-Term Investments	0.07	0.02	0.22	0.09	0.24
Cash Growth	236.13%	-90.03%	139.18%	-61.47%	765.77%
Other Receivables	0.05	-	-	-	-
Receivables	0.05	-	-	-	-
Prepaid Expenses	0.16	0.16	0.16	0.2	0.18
Other Current Assets	0	0.01	0.02	0.02	0.03
Total Current Assets	0.29	0.2	0.41	0.31	0.45
Other Long-Term Assets	-	-	-	-	0
Total Assets	0.29	0.2	0.41	0.31	0.45
Accounts Payable	1.89	1.47	0.68	0.22	0.19
Accrued Expenses	5.57	4.75	4.22	3.12	3.08
Short-Term Debt	9.6	8.32	7	4.66	3.31
Current Portion of Long-Term Debt	0.99	1.08	0.91	1.83	1.49
Other Current Liabilities	0.78	0.19	0.24	0.3	0.32
Total Current Liabilities	18.82	15.81	13.04	10.14	8.4
Total Liabilities	18.82	15.81	13.04	10.14	8.4
Common Stock	0.05	0.04	0.04	0.03	0.03
Additional Paid-In Capital	27.6	26.01	23.67	21.32	17.72
Retained Earnings	-46.18	-41.67	-36.35	-31.18	-25.71
Total Common Equity	-18.54	-15.61	-12.64	-9.83	-7.95
Shareholders' Equity	-18.54	-15.61	-12.63	-9.83	-7.95
Total Liabilities & Equity	0.29	0.2	0.41	0.31	0.45
Total Debt	10.58	9.4	7.9	6.5	4.81
Net Cash (Debt)	-10.51	-9.37	-7.68	-6.4	-4.56
Net Cash Per Share	-0.25	-0.25	-0.22	-0.19	-0.16
Filing Date Shares Outstanding	67.95	41.02	38.16	34.44	32.66
Total Common Shares Outstanding	45.04	39.83	36.08	34.36	32.54
Working Capital	-18.54	-15.61	-12.63	-9.83	-7.95
Book Value Per Share	-0.41	-0.39	-0.35	-0.29	-0.24
Tangible Book Value	-18.54	-15.61	-12.64	-9.83	-7.95
Tangible Book Value Per Share	-0.41	-0.39	-0.35	-0.29	-0.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.